Präzision der Prognose von Nierenerkrankungen bei Diabetes mellitus Typ 2
Authors:
Open Access
- 13 March 2023
- journal article
- research article
- Published by Springer Nature in Die Nephrologie
- Vol. 18 (3) , 147-152
Abstract
No abstract availableKeywords
Funding Information
- University of Innsbruck and Medical University of Innsbruck
This publication has 13 references indexed in Scilit:
- Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trialDiabetologia, 2021
- Intra-individual variability of eGFR trajectories in early diabetic kidney disease and lack of performance of prognostic biomarkersScientific Reports, 2020
- Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) StudyJournal of the American Society of Nephrology, 2020
- The ERA-EDTA Registry Annual Report 2017: a summaryClinical Kidney Journal, 2020
- Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trialThe Lancet Diabetes & Endocrinology, 2020
- A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetesNature Medicine, 2019
- Cumulative Risk of End-Stage Renal Disease Among Patients With Type 2 Diabetes: A Nationwide Inception Cohort StudyDiabetes Care, 2019
- Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and MortalityJAMA, 2014
- Markers of and Risk Factors for the Development and Progression of Diabetic Kidney DiseaseAmerican Journal of Kidney Diseases, 2014
- Chapter 1: Definition and classification of CKDKidney International Supplements, 2013